Table 2.
Clinical Characteristics of NAFLD+CHD Patients and NAFLD Patients
| Parameters | NAFLD+CHD (n = 156) | NAFLD (n = 146) | Statistics | P value |
|---|---|---|---|---|
| Male/Female | 76/80 | 81/65 | χ2 = 0.421 | 0.516 |
| Age, y | 64.00 (59.00, 72.75) | 64.00 (45.00, 74.00) | Z = − 0.644 | 0.520 |
| BMI, kg/m2 | 25.47 (23.05, 27.68) | 26.35 (24.86, 28.49) | Z = −3.431 | 0.001 |
| ALT, U/L | 23.58 (16.07, 34.36) | 22.67 (18.30, 35.68) | Z = − 0.919 | 0.358 |
| AST, U/L | 21.29 (16.80, 32.02) | 21.55 (18.38, 28.09) | Z = − 0.647 | 0.517 |
| GGT, U/L | 30.70 (21.31, 42.67) | 32.55 (20.97, 47.79) | Z = − 0.986 | 0.324 |
| ALP, U/L | 79.52 (66.58, 96.46) | 68.48 (59.09, 81.81) | Z = −3.124 | 0.002 |
| TG, mmol/L | 1.58 (1.13, 2.18) | 1.54 (1.16, 2.21) | Z = −0.145 | 0.885 |
| TC, mmol/L | 4.64 (3.75, 5.54) | 5.42 (4.98, 6.02) | Z = −1.682 | 0.093 |
| HDL, mmol/L | 1.02 (0.88, 1.12) | 1.19 (1.05, 1.32) | Z = −6.741 | < 0.001 |
| LDL, mmol/L | 2.86 (2.10, 3.45) | 3.30 (2.97, 3.52) | Z = − 1.332 | 0.183 |
| TBIL, μmol/L | 12.70 (9.70, 16.77) | 12.00 (10.00, 14.90) | Z = − 0.842 | 0.040 |
| FPG, mmol/L | 5.70 (4.68, 6.96) | 4.96 (4.52, 5.79) | Z = −3.503 | < 0.001 |
Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; FPG, fasting plasma glucose; GGT, γ-glutamyltransferase; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TBIL, total bilirubin; TC, total cholesterol; TG, triglyceride